Shenzhen Mindray Bio-Medical Electronics revenue and financials
¥161.32Change from previous close: +1.45%Absolute change: +¥2.31
In the fiscal year ended December 2025, Shenzhen Mindray Bio-Medical Electronics reported revenue of ¥33.28B (−9.38% year over year). Net income was ¥8.14B, a net margin of 24.4%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- −9.38%
- 2025 vs 2024
- Net income growth
- −30.28%
- 2025 vs 2024
- Net margin
- 24.4%
- 2024: 31.8%
Financial data
Amounts in millions of CNY; per-share values in CNY; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Total revenue | 9,395 | 8,352 | 7,448 | — | 8,506 | 8,237 |
| Cost of revenue | 3,766 | 3,185 | 3,379 | — | 3,331 | 3,087 |
| Gross profit | 5,629 | 5,167 | 4,069 | — | 5,175 | 5,150 |
| Selling, general and administrative | -768 | 1,584 | -2,981 | — | -731 | 1,520 |
| Research and development | 768 | 802 | 1,144 | — | 840 | 767 |
| Operating income | 3,219 | 2,792 | 1,046 | — | 2,780 | 2,935 |
| EBIT | 3,021 | 2,547 | 780 | 2,991 | 2,868 | — |
| EBITDA | 3,021 | 2,547 | 780 | 2,991 | 2,868 | — |
| Interest expense | 5.9 | 6.1 | 7.3 | 6.5 | 5.3 | — |
| Pre-tax income | 3,015 | 2,541 | 772 | — | 2,863 | 3,054 |
| Income tax | 394 | 115 | 135 | — | 323 | 362 |
| Net income | 2,467 | 2,330 | 566 | — | 2,440 | 2,629 |
| Net income to common shareholders | 2,467 | 2,330 | 566 | — | 2,440 | 2,629 |
| Basic EPS | — | 1.92 | — | — | — | 2.17 |
| Diluted EPS | — | 1.92 | — | — | — | 2.17 |
| Average shares (basic) | — | 1,212 | — | — | — | 1,211 |
| Average shares (diluted) | — | 1,212 | — | — | — | 1,211 |